The Bariatric Surgery Journal

Peer-reviewed clinical research, surgical technique analyses, and evidence-based perioperative safety guides curated by board-certified bariatric specialists in Turkiye.

Editorial Mission

Bridging the gap between high-complexity surgical research and patient advocacy, The Bariatric Surgery Journal serves as a premier clinical repository. We synthesize international literature, bariatric surgical standards, and long-term metabolic outcomes to empower patients worldwide with transparent, peer-reviewed medical clarity.




Staple Line Reinforcement in Bariatric Surgery
Surgical Biomechanics • 8 min read

Staple Line Reinforcement vs. Omental Padding

Comparing bioabsorbable polymer materials with oversewing and omentopexy techniques to reduce bleeding and leak rates in laparoscopic sleeve gastrectomy.

GLP-1 Receptor Agonists vs Bariatric Surgery
Pharmacotherapy • 8 min read

GLP-1 Receptor Agonists vs. Bariatric Interventions

A clinical comparison of modern weight-loss medications and metabolic surgery, evaluating EWL percentages, side-effect profiles, and long-term efficacy.

Gut Microbiome Shift in Bariatric Surgery
Metabolic Health • 7 min read

Gut Microbiome Shift & Weight Regain Prevention

Exploring how intestinal flora diversity influences metabolic rate post-treatment and how targeted prebiotics mitigate late-stage weight regain.

Sarcopenic Obesity Muscle Preservation Protocols
Body Composition • 8 min read

Sarcopenic Obesity: Muscle Preservation Protocols

Addressing fat loss without lean muscle wasting: Tailored protein distribution, resistance training guidelines, and metabolic monitoring in clinical bariatric care.



Clinical Deep Dives & Partner Dossiers

Explore comprehensive clinical investigations hosted on our partner platform, Obesity Clinic (obesityclinic.com.tr). These multi-part research files dissect complex metabolic protocols, surgical candidacy criteria, and advanced perioperative safety standards.



Clinical Fast Fact

Did you know? Intestinal bypass procedures (such as Roux-en-Y and Mini Gastric Bypass) stimulate immediate distal L-cell incretin hypersecretion, triggering Type 2 Diabetes glycemic remission in over 75% of patients often days before substantial weight loss occurs.



Scientific & Medical Disclaimer

The information provided in The Bariatric Surgery Journal is compiled for educational and academic research purposes only. It does not constitute formal medical advice, diagnosis, or treatment plans. Patients must consult with board-certified surgeons to evaluate individual medical candidacy.